tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

TSE:NGEN Stock Latest News

NervGen Pharma to Showcase Innovative Neurorestorative Therapies at Oppenheimer Conference
Company AnnouncementsNervGen Pharma to Showcase Innovative Neurorestorative Therapies at Oppenheimer Conference
1d ago
NervGen Pharma price target raised to C$4.50 from C$3 at Raymond James
PremiumThe Fly
NervGen Pharma price target raised to C$4.50 from C$3 at Raymond James
15d ago
NervGen upgraded to Outperform from Market Perform at Raymond James
PremiumThe Fly
NervGen upgraded to Outperform from Market Perform at Raymond James
15d ago
NervGen Pharma Advances Clinical Trials for Spinal Cord Injury
PremiumCompany Announcements
NervGen Pharma Advances Clinical Trials for Spinal Cord Injury
29d ago
NervGen Pharma Launches Equity Program for Flexibility
PremiumCompany Announcements
NervGen Pharma Launches Equity Program for Flexibility
1M ago
NervGen Pharma Nears Trial Enrollment Completion
PremiumCompany AnnouncementsNervGen Pharma Nears Trial Enrollment Completion
3M ago
NervGen Pharma to Present Innovative Treatments
Premium
Company Announcements
NervGen Pharma to Present Innovative Treatments
3M ago
NervGen Pharma Advances Spinal Injury Treatment Trial
Premium
Company Announcements
NervGen Pharma Advances Spinal Injury Treatment Trial
4M ago
NervGen Pharma Spotlights Spinal Injury Treatment
PremiumCompany Announcements
NervGen Pharma Spotlights Spinal Injury Treatment
4M ago
NervGen Pharma Highlights SCI Treatment Advances
PremiumCompany Announcements
NervGen Pharma Highlights SCI Treatment Advances
5M ago
NervGen Pharma to Present at Global Investment Conference
PremiumCompany Announcements
NervGen Pharma to Present at Global Investment Conference
5M ago
NervGen Pharma Excels in Clinical Trials and Drug Development
PremiumCompany Announcements
NervGen Pharma Excels in Clinical Trials and Drug Development
5M ago
NervGen Pharma Showcases at Major Growth Conference
PremiumCompany AnnouncementsNervGen Pharma Showcases at Major Growth Conference
6M ago
NervGen Pharma Issues New Stock Options
Premium
Company Announcements
NervGen Pharma Issues New Stock Options
6M ago
NervGen Pharma Strengthens Board for Clinical Advancements
Premium
Company Announcements
NervGen Pharma Strengthens Board for Clinical Advancements
6M ago
NervGen Pharma initiated with a Market Perform at Raymond James
PremiumThe Fly
NervGen Pharma initiated with a Market Perform at Raymond James
7M ago
NervGen Pharma Advances NVG-300 for Neurological Disorders
PremiumCompany Announcements
NervGen Pharma Advances NVG-300 for Neurological Disorders
7M ago
NervGen Pharma Updates at SCI Investor Symposium
PremiumCompany Announcements
NervGen Pharma Updates at SCI Investor Symposium
7M ago
NervGen Pharma Unveils New Stock Options Plan
PremiumCompany Announcements
NervGen Pharma Unveils New Stock Options Plan
8M ago
NervGen Pharma Shareholders Endorse Board and Plans
PremiumCompany AnnouncementsNervGen Pharma Shareholders Endorse Board and Plans
8M ago
NervGen Pharma Highlights SCI Treatment Advances
Premium
Company Announcements
NervGen Pharma Highlights SCI Treatment Advances
9M ago
NervGen Pharma Delays Trial Enrollment, Secures Funding
Premium
Company Announcements
NervGen Pharma Delays Trial Enrollment, Secures Funding
9M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >